– USA, NY – Mana Health, an NYC-based healthcare technology company, today introduced Jay Yadav, MD, to its Board of Directors and as an investor in the company. The financing will be used to support ongoing operations including deployments for its ManaCloud Platform, designed to streamline the deployment of applications that impact the transition to value-based care.
Dr. Yadav joins the investor team including Reggie Bradford, SVP of Product Development at Oracle and Founder/CEO of Vitrue, Inc., and Bert Ellis, a founding investor in WebMD and CEO of Ellis Capital, along with other esteemed investors and entrepreneurs.
“I’m very impressed by the platform that Mana Health has built to innovate within the data layer of healthcare, and am honored to join its Board of Directors,” stated Dr. Yadav. “Mana’s technology has huge implications for how we can leverage data and innovative applications to solve some of the biggest problems in healthcare delivery, and I’m excited to provide my insights and expertise to this amazing team.”
Dr. Yadav is an internationally recognized interventional cardiologist and entrepreneur who was Founder and CEO of CardioMEMS, Inc. prior to its acquisition by St. Jude Medical in 2014. He was the founder of Angioguard (acquired by JNJ) and initial investor and director of SMART Therapeutics (acquired by Boston Scientific). Dr. Yadav has authored two books, over two hundred publications, and holds over forty patents. Dr. Yadav’s research has significantly improved the treatment of heart failure and cerebrovascular disease, and his procedure for the treatment of carotid artery disease is a Class I recommendation of the National Guidelines of the American Heart Association and the American College of Cardiology. He is the recipient of the Ellis Island Medal of Honor for his contributions to medicine.
“We are honored and excited to expand our Board and investor team with Dr. Yadav, who has an impressive track record of building successful technology companies that help move healthcare forward,” said Raj Amin, Co-Founder, Board Member and Executive Chairman, Mana Health. “The addition of Dr. Yadav, along with our current investor team and advisory board members, continues to bring us the experiences we need to build products for present needs while transforming the future state of healthcare.”
Mana Health developed and recently launched its ManaCloudTM Platform as a way for health systems and healthcare innovators to leverage its technology to accelerate innovation in healthcare. ManaCloud™ unifies data from existing clinical sources like HIE’s and EMRs with the exploding amount of patient-generated data from apps and connected devices to get data on weight, pain levels, pulse, heart rate, exercise, calories and more. All of the data is made available through an extensible API that makes it easy and cost-effective to deliver new services that involve patients and can accelerate the industry-wide movement toward value-based care. To-date, more than 100 developers have signed up to access ManaCloud to deliver their applications, covering areas from patient engagement and chronic condition management to clinical trials and population health.
About Mana Health
Mana Health is a leading technology company that is transforming healthcare and accelerating the shift toward value-based care with its ManaCloud™ Platform and other technology solutions. Based in New York City, the Mana Health team includes experts from healthcare integration, real-time data systems, application development, and clinical applications. The ManaCloud™ Platform is a cloud-based, secure platform that integrates data from EMR’s with devices and patient generated data and supports the needs of a variety of healthcare applications through its standards-based API. Developers can sign up for access to ManaCloud at Mana Health’s website. Mana Health was the awarded the contract for the Patient Portal for New Yorkers and was selected to deploy its ManaPortal in San Antonio Texas, powered by ManaCloud.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
